Bisphosphonates have been safely used to treat osteoporosis, effectively reducing fracture risk after 3 to 5 years of treatment. Recent concerns about long-term safety coupled with posttreatment fracture risk reduction have increased support for drug holidays. The decision to start low-risk patients on drug holidays must be based on current fracture risk assessment.

Contents Contents Commentary Technical Notes Tables Section 1 Diagnoses of HIV Infection and Diagnoses of Infection Classified as Stage 3 (AIDS) 1a Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2011-2016-United States 1b Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2011-2016-United States and 6 dependent areas 2a Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2011-2016 and cumulative-United States 2b Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2011-2016 and cumulative-United States and 6 dependent areas 3a Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2016-United States 3b Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2016-United States and 6 dependent areas 4a Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2016-United States 4b Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2016-United States and 6 dependent areas 5a Diagnoses of HIV infection attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by selected characteristics, 2011-2016-United States 5b Diagnoses of HIV infection attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by selected characteristics, 2011-2016-United States and 6 dependent areas 6a Diagnoses of HIV infection attributed to injection drug use, by selected characteristics, 2011-2016-United States 6b Diagnoses of HIV infection attributed to injection drug use, by selected characteristics, 2011-2016-United States and 6 dependent areas 7a Diagnoses of HIV infection attributed to heterosexual contact, by selected characteristics, 2011-2016-United States 7b Diagnoses of HIV infection attributed to heterosexual contact, by selected characteristics, 2011-2016-United States and 6 dependent areas 8a Stage 3 (AIDS) attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by selected characteristics, 2011-2016-United States 8b Stage 3 (AIDS) attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by selected characteristics, 2011-2016-United States and 6 dependent areas  HIV Surveillance Report 4 Vol. 28 Section 2 Deaths and Survival after a Diagnosis of HIV Infection or Stage 3 (AIDS) Classification 16a Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2011-2015-United States 16b Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2011-2015-United States and 6 dependent areas 17a Deaths of persons with diagnosed HIV infection ever classified as stage (AIDS), by year of death and selected characteristics, 2011-2015 and cumulative-United States 17b Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and selected characteristics, 2011-2015 and cumulative-United States and dependent areas 18a Deaths of...